These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19822419)

  • 1. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
    Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G
    Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.
    Graziano F; Ruzzo A; Santini D; Humar B; Tonini G; Catalano V; Berardi R; Pizzagalli F; Arduini F; Bearzi I; Scartozzi M; Cascinu S; Testa E; Ficarelli R; Magnani M
    J Clin Oncol; 2005 Apr; 23(10):2339-45. PubMed ID: 15800325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population.
    Al-Moundhri MS; Alkindy M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Habsi H; Ganguly SS; Tanira M
    J Clin Gastroenterol; 2009 Feb; 43(2):152-6. PubMed ID: 18779738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH; Hua D; Li LH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer.
    Glas J; Török HP; Schneider A; Brünnler G; Kopp R; Albert ED; Stolte M; Folwaczny C
    J Clin Oncol; 2004 Dec; 22(23):4746-52. PubMed ID: 15570075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
    Vishnoi M; Pandey SN; Choudhuri G; Mittal B
    Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
    Ruzzo A; Graziano F; Kawakami K; Watanabe G; Santini D; Catalano V; Bisonni R; Canestrari E; Ficarelli R; Menichetti ET; Mari D; Testa E; Silva R; Vincenzi B; Giordani P; Cascinu S; Giustini L; Tonini G; Magnani M
    J Clin Oncol; 2006 Apr; 24(12):1883-91. PubMed ID: 16622263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.
    Goekkurt E; Al-Batran SE; Hartmann JT; Mogck U; Schuch G; Kramer M; Jaeger E; Bokemeyer C; Ehninger G; Stoehlmacher J
    J Clin Oncol; 2009 Jun; 27(17):2863-73. PubMed ID: 19332728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
    Lahner E; Corleto VD; D'Ambra G; Di Giulio E; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2008 Feb; 27(4):355-65. PubMed ID: 18047563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.
    Achyut BR; Srivastava A; Bhattacharya S; Mittal B
    Clin Chim Acta; 2007 Feb; 377(1-2):163-9. PubMed ID: 17069782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer].
    He X; Jiang L; Fu B; Zhang X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):685-8. PubMed ID: 12133467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.
    Liang J; Jiang T; Yao RY; Liu ZM; Lv HY; Qi WW
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):493-500. PubMed ID: 19960344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence.
    Perri F; Piepoli A; Bonvicini C; Gentile A; Quitadamo M; Di Candia M; Cotugno R; Cattaneo F; Zagari MR; Ricciardiello L; Gennarelli M; Bazzoli F; Ranzani GN; Andriulli A
    Cytokine; 2005 Jun; 30(5):293-302. PubMed ID: 15927855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.